Now in it’s 11th year, the aim of BioTrinity is simple – create an ideal networking and partnering platform for life science companies across the world to meet all under one roof and catalyse business in the industry, to ultimately help shape our healthcare future.
BioTrinity offers unique access to global life science investors, big pharma executives and innovative CEO’s of emerging R&D companies seeking to make deals and grow their networks.
OBN is the organiser of BioTrinity and is also the not-for-profit Membership organisation supporting and bringing together innovative life science R&D companies, their corporate partners and their investors.
